Respuesta discordante a terapia antirretroviral altamente activa en pacientes pediátricos mexicanos infectados con VIH/SIDA - Discordant response to highly active antiretroviral therapy in Mexican pediatric patients infected with HIV/AIDS
Romanomazzotti, L.; Sifuentesvela, C.; Villalobosacosta, P.; Santospreciado, J.I.; Paviaruz, N.
Boletin Medico del Hospital Infantil de Mexico (Ed. Espanola) 66(4): 335-342
2009
ISSN/ISBN: 0539-6115 Document Number: 258576
Document emailed within 1 workday
Related Documents
Capristogonzalez, F.; Barraganperez, E.; Paviaruiz, N.; Villalobosacosta, P.; Hernandezhernandez, M.; Huertahurtado, A.; Hernandezaguilar, J.; Garzamorales, S. 2008: Manifestaciones neurológicas en pacientes pediátricos y adolescentes mexicanos infectados con VIH/SIDA. Experiencia del Hospital Infantil de México Federico Gómez - Neurological manifestations in Mexican pediatric and adolescent patients infected with HIV/AIDS. expérience in the Hospital Infantil de Mexico Federico Gomez Boletin Medico del Hospital Infantil de Mexico (Ed. Espanola) 65(1): 6-12Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Palacios, G.C.; Montalvo, M.S.; Fraire, M.I.; Leon, E.; Alvarez, M.T.; Solorzano, F. 2008: Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy International Journal of Pediatric Otorhinolaryngology 72(11): 1671-1681
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Deng, X.-j.; He, Y.; Yang, L.; Zou, S.-p.; Yang, H.; Zheng, Y.-h. 2011: The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients Zhonghua Nei Ke Za Zhi 50(3): 230-234
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935
Silveira, M.P.T.; Guttier, M.íl.C.; Pinheiro, C.A.T.; Pereira, T.V.S.; Cruzeiro, A.L.S.; Moreira, L.B. 2012: Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy Revista Brasileira de Psiquiatria 34(2): 162-167
Mohammadpour, A.; Yekta, Z.P.; Nikbakht Nasrabadi, A.R. 2010: HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study Nursing and Health Sciences 12(4): 464-469
Werneck-Silva, A.L.; Prado, I.B. 2009: Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy Journal of Gastroenterology and Hepatology 24(1): 135-139
Baiocchi, O.C.G.; Colleoni, G.W.B.; Navajas, E.V.; Duarte, L.Claudio.C.; Alves, A.C.; Andrade, A.Lucia.S.S.; Kerbauy, J.; Oliveira, J.Salvador.R. 2002: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma Acta Oncologica 41(2): 192-196
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Pornprasert, S.; Sonboon, P.; Kiatwattanacharoen, S.; Klinbuayaem, V.; Leenasirimakul, P.; Promping, C.; Inta, P.; Ajhan, S.; Leechanachai, P. 2009: Evolution of hematological parameters in HIV-1-infected patients with and without thalassemia carriages during highly active antiretroviral therapy HIV Clinical Trials 10(2): 88-93
Ayena, K.D.; Amedome, K.M.; Agbo, A.; Kpetessouayivon, A.L.; Dzidzinyo, B.K.; Djagnikpo, P.A.; Banla, M.; Balo, K.P. 2010: Atteintes Oculaires chez les Personnes Vivant avec le Vih/Sida Sous Trithérapie au Togo - Ocular Manifestations in Hiv/Sida Patients Undergoing Highly Active Antiretroviral Treatment (Haart) in Togo Medecine Tropicale 70(2): 137-140